AnaptysBio (ANAB) Stock Chart & Stock Price History $30.04 -0.21 (-0.69%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.97%, with a year-to-date return of 126.89%. In the past month, the stock has increased 37.17%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $30.25 with a market cap of $847 million and volume of 258,041 shares. Five years ago, the stock traded at $16.32, representing a 84.07% increase over that period. At the time, it had a market cap of $445.60 million and a volume of 123,532 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.15%1 Month Performance+37.17%3 Month Performance+28.10%Year-To-Date Performance+126.89%1 Year Performance-8.97%5 Year Performance+84.07% ANAB Stock Chart for Tuesday, October, 7, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$30.94$30.25-2.23%$31.29$29.91258,041 shs$847 million10/03/2025$31.34$30.94-1.28%$32.24$30.66353,578 shs$866.32 million10/02/2025$31.97$31.34-1.97%$32.15$30.00807,473 shs$877.52 million10/01/2025$30.62$31.97+4.41%$33.48$30.54828,397 shs$895.06 million09/30/2025$23.27$30.62+31.59%$32.50$25.003.75 million shs$857.36 million09/29/2025$23.58$23.27-1.31%$24.10$23.15470,839 shs$651.56 million09/26/2025$22.04$23.58+6.99%$23.99$20.79590,055 shs$660.24 million09/25/2025$22.14$22.04-0.45%$22.52$21.76391,366 shs$617.12 million09/24/2025$20.95$22.14+5.68%$23.59$21.00741,013 shs$619.92 million09/23/2025$21.40$20.95-2.10%$21.63$20.72353,551 shs$586.60 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$20.84$21.40+2.69%$21.58$20.49457,351 shs$599.20 million09/19/2025$21.08$20.84-1.14%$21.45$20.68679,572 shs$583.52 million09/18/2025$19.81$21.08+6.41%$21.23$19.66510,080 shs$554.62 million09/17/2025$19.40$19.81+2.11%$20.40$19.47718,387 shs$554.68 million09/16/2025$20.16$19.40-3.77%$20.33$17.111.36 million shs$543.20 million09/15/2025$23.40$20.16-13.85%$24.07$20.16966,699 shs$564.42 million09/12/2025$23.20$23.40+0.86%$23.58$22.87472,652 shs$655.13 million09/11/2025$22.78$23.20+1.84%$23.64$22.78425,402 shs$649.60 million09/10/2025$22.13$22.78+2.94%$22.80$22.01499,011 shs$637.84 million09/09/2025$22.19$22.13-0.27%$22.32$21.88368,991 shs$619.57 million09/08/2025$21.90$22.19+1.32%$22.65$21.56607,096 shs$621.32 million Related Companies NewAmsterdam Pharma Stock Chart Viking Therapeutics Stock Chart Amneal Pharmaceuticals Stock Chart Centessa Pharmaceuticals Stock Chart Xenon Pharmaceuticals Stock Chart CG Oncology Stock Chart uniQure Stock Chart Ultragenyx Pharmaceutical Stock Chart Apellis Pharmaceuticals Stock Chart Immunovant Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
